The discovery of steroids and other novel FKBP inhibitors using a molecular docking program

Journal of Molecular Biology

Volumn 287, Issue 5, 1999, Pages 853-858

  Burkhard, P ^a   Hommel, U ^a   Sanner, M ^a   Walkinshaw, M D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FK 506 BINDING PROTEIN; PROTEIN INHIBITOR; STEROID;

ARTICLE; COMPUTER PROGRAM; DATA BASE; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 0033574397     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2621     Document Type: Article

References (24)

1. Ajay, Murcko M. A. Computational methods to predict binding free-energy in ligand-receptor complexes. J. Med. Chem. 38:1995;4953-4967.
2. Allen F. H., Davies J. E., Galloy J. J., Johnson O., Kennard O., Macrae C. R., Mitchell E. M., Mitchell G. R., Smith J. M., Watson D. G. The development of version-3 and version-4 of the Cambridge Structural Database system. J. Chem. Info. Comp. Sci. 31:1991;187-204.
3. Bohm H. J. Ludi-rule-based automatic design of new substituents for enzyme- inhibitor leads. J. Comp. Aided Mol. Design. 6:1992;593-606.
4. Bohm H. J. Towards the automatic design of synthetically accessible protein ligands - peptides, amides and peptidomimetics. J. Comp. Aided Mol. Design. 10:1996;265-272.
5. Bohm H. J., Klebe G. What can we learn from molecular recognition in protein-ligand complexes for the design of new drugs? Ange. Chemie Int. Edit. 35:1996;2589-2614.
6. Burkhard P., Taylor P., Walkinshaw M. D. An example of a protein ligand found by database mining: description of the docking method and its verification by a 2.3Å X-ray structure of a thrombin-ligand complex. J. Mol. Biol. 277:1998;449-466.
7. Desjarlais R. L., Sheridan R. R., Seibel G. L., Dixon J. S., Kuntz I. D., Venkataraghavan R. Using shape complementarity as an initial screen in designing ligands for a receptor-binding site of known 3-dimensional structure. J. Med. Chem. 31:1988;722-729.
8. Galat A., Metcalfe S. M. Peptidylproline cis/trans isomerases. Prog. Biophys. Mol. Biol. 63:1995;67-118.
9. Goodford P. J. A computational-procedure for determining energetically favorable binding-sites on biologically important macromolecules. J. Med. Chem. 28:1985;849-857.
10. Guner O. F., Hughes D. W., Dumont L. M. An integrated approach to 3-dimensional information management with maccs-3d. J. Chem. Info. Comp. Sci. 31:1991;408-414.
11. Hajduk P. J., Meadows R. P., Fesik S. W. Drug design - discovering high-affinity ligands for proteins. Science. 278:1997;497.
12. Knegtel R. M. A., Kuntz I. D., Oshiro C. M. Molecular docking to ensembles of protein structures. J. Mol. Biol. 266:1997;424-440.
13. Lepre C. A., Thomson J. A., Moore J. M. Solution structure of fk506 bound to fkbp-12. FEBS Letters. 302:1992;89-96.
14. Petros A. M., Gampe R. T., Gemmecker G., Neri P., Holzman T. F., Edalji R., Hochlowski J., Jackson M., Mcalpine J., Luly J. R., Pilotmatias T., Pratt S., Fesik S. W. NMR-studies of an fk-506 analog, [u-c-13]ascomycin, bound to fkbp - conformation and regions of ascomycin involved in binding. J. Med. Chem. 34:1991;2925-2928.
15. Philippsen A. DINO. A Visualisation System for Structural Data. 1998;University of Basel.
16. Ratajczak T., Carrello A. Cyclophilin-40 (cyp-40), mapping of its hsp90 binding domain and evidence that fkbp52 competes with cyp-40 for hsp90 binding. J. Biol. Chem. 271:1996;2961-2965.
17. Rosen M. K., Michnick S. W., Karplus M., Schreiber S. L. Proton and nitrogen sequential assignments and secondary structure determination of the human fk506 and rapamycin binding-protein. Biochemistry. 30:1991;4774-4789.
18. Sanner M. F., Olson A. J., Spehner J. C. Reduced surface - an efficient way to compute molecular-surfaces. Biopolymers. 38:1996;305-320.
19. Schmid F. X., Mayr L. M., Mucke M., Schonbrunner E. R. Prolyl isomerases - role in protein-folding. Advan. Protein Chem. 44:1993;25-66.
20. Schreiber S. L., Albers M. W., Brown E. J. The cell-cycle, signal-transduction, and immunophilin ligand complexes. Acc. Chem. Res. 26:1993;412-420.
21. Shuker S. B., Hajduk P. J., Meadows R. P., Fesik S. W. Discovering high-affinity ligands for proteins - sar by NMR. Science. 274:1996;1531-1534.
22. Somoza J. R., Skillman A. G., Munagala N. R., Oshiro C. M., Knegtel R. M. A., Mpoke S., Fletterick R. J., Kuntz I. D., Wang C. C. Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan. Biochemistry. 37:1998;5344-5348.
23. Vanduyne G. D., Standaert R. F., Karplus P. A., Schreiber S. L., Clardy J. Atomic structures of the human immunophilin fkbp-12 complexes with fk506 and rapamycin. J. Mol. Biol. 229:1993;105-124.
24. Xu R. X., Nettesheim D., Olejniczak E. T., Meadows R., Gemmecker G., Fesik S. W. H-1, C-13, and N-15 assignments and secondary structure of the W 06 binding-protein when bound to ascomycin. Biopolymers. 33:1993;535-550.